RVMD (Revolution Medicines, Inc.) Stock Market Reviews

crown

search

Read and share opinions on RVMD (Revolution Medicines, Inc.) stock. Join MyTopStock.com to discover reviews, insights, and discussions from investors about this company's performance in the stock mark

RVMD

Revolution Medicines, Inc.

clarify Biotechnology

bookmark Healthcare

public United States

Sell Neutral Buy

Latest News

Revolution Medicines (RVMD): Assessing Valuation After Recent 28% Monthly Share Price Surge
Nov 7, 2025
Revolution Medicines Posts Wider-Than-Expected Loss in Q3, Sales Nil
Nov 6, 2025
Revolution Medicines Inc (RVMD) Q3 2025 Earnings Call Highlights: Strategic Advances Amid ...
Nov 6, 2025
Revolution Medicines to Participate in November 2025 Investor Conferences
Nov 4, 2025
Revolution Medicines to Report Financial Results for Third Quarter 2025 After Market Close on November 5, 2025
Oct 29, 2025
Revolution Medicines’ RAS(ON) Multi-Selective Inhibitor Daraxonrasib Granted U.S. FDA Orphan Drug Designation in Pancreatic Cancer
Oct 27, 2025
Revolution Medicines to Present Updated Elironrasib Safety and Efficacy Data in Patients with KRAS G12C Non-Small Cell Lung Cancer Following Treatment with a KRAS(OFF) G12C Inhibitor
Oct 22, 2025
Revolution Medicines (RVMD): Examining Valuation After Recent Stock Momentum and Long-Term Gains
Oct 20, 2025
Jim Cramer Says Revolution Medicines “Is a Speculative Situation”
Oct 19, 2025
Revolution Medicines Awarded Voucher for Daraxonrasib (RMC-6236) Under FDA Commissioner's National Priority Voucher Pilot Program
Oct 17, 2025
Revolution Medicines, Inc. (RVMD) Insider Sells Shares
Oct 2, 2025

Reviews